Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)

Vanderkerken, Karin (Administrative Promotor)
Thielemans, Kris (Administrative Promotor)
Vanderkerken, Karin (Co-Promoter)
Breckpot, Karine (Co-Promoter)

!!Description

Antitumorvaccinatie vereist de identificatie van doelwitantigenen op resistente tumorsubpopulaties, adequate immuuncompetentie van de patiënten en de beschikbaarheid van efficiënte vaccinatietechnieken.

Acroniem	SRP48
Status	Actief
Effectieve start/einddatum	1/11/17 → 31/10/24

Flemish discipline codes

Cancer therapy

59 Article
10 Unpublished abstract
2 Poster
2 Scientific review

Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer: A Proposal for Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring
Locy, H., Verhulst, S., Cools, W., Waelput, W., Brock, S., Cras, L., Schiettecatte, A., Jonckheere, J., van Grunsven, L. A., Vanhoeij, M., Thielemans, K. & Breckpot, K., 11 feb 2022, In: Frontiers in Immunology. 13, 794175.
Onderzoeksoutput: Article › peer review

Open Access
Bestand
3 Citaten (Scopus)

45 Downloads (Pure)
T-cell subsets in the skin and their role in inflammatory skin disorders
Kortekaas Krohn, I., Aerts, J. L., Breckpot, K., Goyvaerts, C., Knol, E., Van Wijk, F. & Gutermuth, J., mrt 2022, In: Allergy. 77, 3, blz. 827-842 16 blz.
Onderzoeksoutput: Scientific review › peer review

Open Access
Bestand
8 Citaten (Scopus)

68 Downloads (Pure)
A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
Nylund, P., Atienza Párraga, A., Haglöf, J., De Bruyne, E., Menu, E., Garrido-Zabala, B., Ma, A., Jin, J., Öberg, F., Vanderkerken, K., Kalushkova, A. & Jernberg-Wiklund, H., 12 feb 2021, In: Cell & Death Disease. 12, 2, 16 blz., 167.
Onderzoeksoutput: Article › peer review

Open Access
Bestand
9 Citaten (Scopus)

144 Downloads (Pure)

1 Afgelopen

SRP14: SRP (Zwaartepunt): Richten op residuele kankercellen: myeloom en melanoom als modelaandoeningen
Thielemans, K. & Vanderkerken, K.
1/11/12 → 31/10/17
Project: Fundamenteel

1 Talk or presentation at a workshop/seminar

Noninvasive imaging and inhibition of human programmed death ligand 1 using nanobody K2 to improve cancer immunotherapy
Karine Breckpot (Speaker)
15 nov 2021
Activiteit: Talk or presentation at a workshop/seminar

Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)

Projectdetails

!!Description

Flemish discipline codes

Onderzoeksoutput

Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer: A Proposal for Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring

T-cell subsets in the skin and their role in inflammatory skin disorders

A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma

projecten

SRP14: SRP (Zwaartepunt): Richten op residuele kankercellen: myeloom en melanoom als modelaandoeningen

Activiteiten

Noninvasive imaging and inhibition of human programmed death ligand 1 using nanobody K2 to improve cancer immunotherapy